BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15766229)

  • 1. Bone morphogenetic proteins and spinal fusion.
    Walker DH; Wright NM
    Neurosurg Focus; 2002 Dec; 13(6):e3. PubMed ID: 15766229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins for spinal fusion.
    Carlisle E; Fischgrund JS
    Spine J; 2005; 5(6 Suppl):240S-249S. PubMed ID: 16291119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of drug delivery to optimize the effects of bone morphogenetic proteins during periodontal regeneration.
    King GN
    Curr Pharm Biotechnol; 2001 Jun; 2(2):131-42. PubMed ID: 11480418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model.
    Morimoto T; Kaito T; Matsuo Y; Sugiura T; Kashii M; Makino T; Iwasaki M; Yoshikawa H
    Spine J; 2015 Jun; 15(6):1379-90. PubMed ID: 25733023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone morphogenetic proteins (BMP): clinical application for reconstruction of bone defects].
    Sierra-García GD; Castro-Ríos R; Gónzalez-Horta A; Lara-Arias J; Chávez-Montes A
    Gac Med Mex; 2016; 152(3):381-5. PubMed ID: 27335195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human bone morphogenic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model.
    Zhang H; Sucato DJ; Welch RD
    Spine (Phila Pa 1976); 2005 Mar; 30(5):512-8. PubMed ID: 15738782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion?
    Cheng JC; Guo X; Law LP; Lee KM; Chow DH; Rosier R
    Spine (Phila Pa 1976); 2002 Mar; 27(5):467-74. PubMed ID: 11880831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenic protein-1 : a review of its utility in spinal applications.
    Brown A; Stock G; Patel AA; Okafor C; Vaccaro A
    BioDrugs; 2006; 20(4):243-51. PubMed ID: 16831023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
    Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
    Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.
    Williams BJ; Smith JS; Fu KM; Hamilton DK; Polly DW; Ames CP; Berven SH; Perra JH; Knapp DR; McCarthy RE; Shaffrey CI;
    Spine (Phila Pa 1976); 2011 Sep; 36(20):1685-91. PubMed ID: 21897187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.
    El Bialy I; Jiskoot W; Reza Nejadnik M
    Pharm Res; 2017 Jun; 34(6):1152-1170. PubMed ID: 28342056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ABCs of BMPs.
    Boden SD
    Orthop Nurs; 2005; 24(1):49-52; quiz 53-4. PubMed ID: 15722975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
    Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
    Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment.
    Lee TC; Ho JT; Hung KS; Chen WF; Chung YH; Yang YL
    Neurosurgery; 2006 Feb; 58(2):373-80; discussion 373-80. PubMed ID: 16462492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of bone morphogenetic proteins 2 and 7 by ex vivo gene therapy in a rat spinal fusion model.
    Kaito T; Johnson J; Ellerman J; Tian H; Aydogan M; Chatsrinopkun M; Ngo S; Choi C; Wang JC
    J Bone Joint Surg Am; 2013 Sep; 95(17):1612-9. PubMed ID: 24005203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent.
    Helm GA; Alden TD; Beres EJ; Hudson SB; Das S; Engh JA; Pittman DD; Kerns KM; Kallmes DF
    J Neurosurg; 2000 Apr; 92(2 Suppl):191-6. PubMed ID: 10763690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.